pyridoxal phosphate has been researched along with Liver Dysfunction in 58 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The MRI characteristics of a multifocal inflammatory pseudotumor of the liver are described." | 5.31 | Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. ( de Hemptinne, B; Elewaut, A; Mortelé, KJ; Praet, M; Ros, PR; Wiesner, W, 2002) |
| " Adverse events and discomfort were recorded and graded in all patients." | 2.42 | Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis. ( de Beeck, BO; Fagertun, H; Fog, AF; Kane, P; Martí-Bonmatí, L, 2003) |
| "Hepatocyte-containing liver neoplasms such as hepatomas or focal nodular hyperplasia (FNH), take up MnDPDP and demonstrate varying degrees of enhancement." | 1.31 | MnDPDP enhanced magnetic resonance imaging of focal liver lesions. ( Burkill, GJ; Healy, JC; King, LJ; Murray-Lyons, I; Scurr, ED; Vlavianos, P, 2002) |
| "The MRI characteristics of a multifocal inflammatory pseudotumor of the liver are described." | 1.31 | Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings. ( de Hemptinne, B; Elewaut, A; Mortelé, KJ; Praet, M; Ros, PR; Wiesner, W, 2002) |
| " Contrast agents were injected according to the currently recommended practices; Gd-DTPA was injected as a rapid bolus injection in a dosage of 0." | 1.29 | Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. ( Brown, ED; Eisenberg, LB; Kettritz, U; Schlund, JF; Semelka, RC; Warshauer, DM, 1996) |
| "After carbon tetrachloride poisoning the enzyme activity in the plasma increased within 2 h but was not enhanced by pyridoxal 5'-phosphate." | 1.26 | Changes in activation of aspartate aminotransferase by pyridoxal 5'-phosphate after experimental liver damage in rabbits. ( Barnard, HC; de Waal, A; le Roux, S; Potgieter, GM; Schoombie, EM, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 23 (39.66) | 18.7374 |
| 1990's | 19 (32.76) | 18.2507 |
| 2000's | 15 (25.86) | 29.6817 |
| 2010's | 1 (1.72) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarrant, J | 1 |
| Meyer, D | 1 |
| Katavolos, P | 1 |
| Harr, KE | 1 |
| Allison, K | 1 |
| Bonde, RK | 1 |
| Murphy, D | 1 |
| Harvey, JW | 1 |
| Seale, MK | 1 |
| Catalano, OA | 1 |
| Saini, S | 4 |
| Hahn, PF | 3 |
| Sahani, DV | 1 |
| Ni, Y | 2 |
| Cresens, E | 1 |
| Adriaens, P | 1 |
| Dymarkowski, S | 1 |
| Bogaert, J | 1 |
| Zhang, H | 1 |
| Bosmans, H | 1 |
| Verbruggen, A | 1 |
| Marchal, G | 2 |
| King, LJ | 1 |
| Burkill, GJ | 1 |
| Scurr, ED | 1 |
| Vlavianos, P | 1 |
| Murray-Lyons, I | 1 |
| Healy, JC | 1 |
| Halavaara, J | 1 |
| Abo-Ramadan, U | 1 |
| Markkola, A | 1 |
| Aronen, H | 1 |
| Häkkinen, AM | 1 |
| Martí-Bonmatí, L | 1 |
| Fog, AF | 1 |
| de Beeck, BO | 1 |
| Kane, P | 1 |
| Fagertun, H | 1 |
| SHEID, B | 1 |
| MORRIS, HP | 1 |
| ROTH, JS | 1 |
| Reimer, P | 1 |
| Schneider, G | 1 |
| Schima, W | 2 |
| Ba-Ssalamah, A | 1 |
| Happel, B | 1 |
| Kettenbach, J | 1 |
| Dirisamer, A | 1 |
| Wrba, F | 1 |
| Längle, F | 1 |
| Faraj, BA | 1 |
| Camp, VM | 1 |
| Caplan, DB | 1 |
| Ahmann, PA | 1 |
| Kutner, M | 1 |
| Dols, JL | 1 |
| van Zanten, AP | 1 |
| de Waal, A | 1 |
| le Roux, S | 1 |
| Potgieter, GM | 1 |
| Barnard, HC | 1 |
| Schoombie, EM | 1 |
| Majumdar, SK | 1 |
| Shaw, GK | 1 |
| O'Gorman, P | 1 |
| Aps, EJ | 1 |
| Offerman, EL | 1 |
| Thomson, AD | 1 |
| Al-Mudhaffar, SA | 1 |
| Naash, M | 1 |
| Matloff, DS | 1 |
| Selinger, MJ | 1 |
| Kaplan, MM | 1 |
| Anderson, BB | 1 |
| O'Brien, H | 1 |
| Griffin, GE | 1 |
| Mollin, DL | 1 |
| Mitchell, DG | 1 |
| Outwater, EK | 1 |
| Matteucci, T | 1 |
| Rubin, DL | 1 |
| Chezmar, JL | 1 |
| Rofsky, NM | 2 |
| Earls, JP | 1 |
| Slater, GJ | 1 |
| Mayo-smith, WW | 1 |
| Sharma, P | 1 |
| Eisenberg, PJ | 1 |
| Kettritz, U | 2 |
| Warshauer, DM | 1 |
| Brown, ED | 1 |
| Schlund, JF | 2 |
| Eisenberg, LB | 2 |
| Semelka, RC | 3 |
| Wilbur, K | 1 |
| Schmid, A | 1 |
| Schmid, H | 1 |
| Wang, C | 1 |
| Jung, G | 1 |
| Heindel, W | 1 |
| Krahe, T | 1 |
| Kugel, H | 1 |
| Walter, C | 1 |
| Fischbach, R | 1 |
| Klaus, H | 1 |
| Lackner, K | 1 |
| Coffin, CM | 1 |
| Diche, T | 1 |
| Mahfouz, A | 1 |
| Alexandre, M | 1 |
| Caseiro-Alves, F | 1 |
| Rahmouni, A | 1 |
| Vasile, N | 1 |
| Mathieu, D | 1 |
| Clément, O | 1 |
| Siauve, N | 1 |
| Cuénod, CA | 1 |
| Vuillemin-Bodaghi, V | 1 |
| Leconte, I | 1 |
| Frija, G | 1 |
| Martin, DR | 1 |
| Chung, JJ | 1 |
| Balci, NC | 1 |
| Wilber, K | 1 |
| Grimm, J | 2 |
| Müller-Hülsbeck, S | 1 |
| Blume, J | 1 |
| Biederer, J | 1 |
| Heller, M | 1 |
| De Gaspari, A | 1 |
| De Cobelli, F | 1 |
| Del Maschio, A | 1 |
| Yoneda, K | 1 |
| Mortelé, KJ | 1 |
| Wiesner, W | 1 |
| de Hemptinne, B | 1 |
| Elewaut, A | 1 |
| Praet, M | 1 |
| Ros, PR | 1 |
| Oudkerk, M | 1 |
| Torres, CG | 1 |
| Song, B | 1 |
| König, M | 1 |
| Fernandez-Cuadrado, J | 1 |
| Op de Beeck, B | 1 |
| Marquardt, M | 1 |
| van Dijk, P | 1 |
| de Groot, JC | 1 |
| Braga, HJ | 1 |
| Choti, MA | 1 |
| Lee, VS | 1 |
| Paulson, EK | 1 |
| Siegelman, ES | 1 |
| Bluemke, DA | 1 |
| Bergmeyer, HU | 2 |
| Bowers, GN | 2 |
| Horder, M | 2 |
| Moss, DW | 2 |
| Scheibe, P | 1 |
| Wahlefeld, AW | 1 |
| Rossouw, JE | 2 |
| Labadarios, D | 2 |
| Davis, M | 2 |
| Williams, R | 3 |
| Jung, K | 1 |
| Ohlrich, B | 1 |
| Mildner, D | 1 |
| Zubek, A | 1 |
| Schimmelpfennig, W | 1 |
| Egger, E | 1 |
| Ratnaike, S | 1 |
| McConnell, JB | 1 |
| Moore, RE | 1 |
| Mitchell, D | 1 |
| Wagner, C | 1 |
| Stone, WJ | 1 |
| Wilkinson, GR | 1 |
| Schenker, S | 1 |
| Rosalki, SB | 1 |
| Bayoumi, RA | 1 |
| Vogl, TJ | 2 |
| Hammerstingl, R | 1 |
| Schnell, B | 2 |
| Eibl-Eibesfeldt, B | 1 |
| Peqios, W | 1 |
| Lissner, J | 2 |
| Hamm, B | 1 |
| Branding, G | 1 |
| Taupitz, M | 1 |
| Wolf, KJ | 1 |
| Weinreb, JC | 2 |
| Andersen, K | 1 |
| Kaad, PH | 1 |
| Bernardino, ME | 2 |
| Young, SW | 3 |
| Lee, JK | 2 |
| Rummeny, EJ | 1 |
| Peters, PE | 1 |
| Weinreb, J | 1 |
| Kakuma, S | 1 |
| Leevy, CB | 1 |
| Frank, O | 1 |
| Baker, H | 1 |
| Simpson, BB | 1 |
| Ratner, AV | 1 |
| Matkin, C | 1 |
| Carter, EA | 1 |
| Zaman, SN | 1 |
| Tredger, JM | 1 |
| Johnson, PJ | 1 |
| Francesconi, G | 1 |
| Mellina, S | 1 |
| Massarrat, S | 1 |
13 reviews available for pyridoxal phosphate and Liver Dysfunction
| Article | Year |
|---|---|
Use of optimized aminotransferase methods in regulated preclinical studies.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Li | 2013 |
Safety and efficacy of Mangafodipir trisodium in patients with liver lesions and cirrhosis.
Topics: Contrast Media; Edetic Acid; Female; Humans; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Magne | 2003 |
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.
Topics: Contrast Media; Edetic Acid; Gadolinium; Gadolinium DTPA; Humans; Liver; Liver Diseases; Liver Neopl | 2004 |
[MRT of the liver. Clinical significance of nonspecific and liver-specific MRT contrast agents].
Topics: Chelating Agents; Contrast Media; Edetic Acid; Gadolinium; Humans; Image Enhancement; Image Interpre | 2004 |
Mangafodipir trisodium injection (Mn-DPDP). A contrast agent for abdominal MR imaging.
Topics: Adrenal Gland Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clini | 1996 |
[Possibilities and limitations of drugs to protect the liver].
Topics: Amino Acids; Animals; Biotin; Carnitine; Fructosediphosphates; Glucose; Immunologic Factors; Ketoglu | 1996 |
Clinical implications of studies with MnDPDP in animal models of hepatic abnormalities.
Topics: Animals; Contrast Media; Disease Models, Animal; Drug Evaluation, Preclinical; Edetic Acid; Humans; | 1997 |
Liver-specific MR imaging contrast agents.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Liver; Liver D | 1998 |
Mechanisms of action of liver contrast agents: impact for clinical use.
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Gadolinium; Humans; Injections, Intraven | 1999 |
[Magnetic resonance imaging of the liver: what kind of contrast agents?].
Topics: Contrast Media; Dextrans; Edetic Acid; Ferrosoferric Oxide; Focal Nodular Hyperplasia; Gadolinium DT | 2001 |
[Aspartate aminotransferase (glutamic oxalacetic transaminase) and alanine aminotransferase (glutamic pyruvic transaminase)].
Topics: Alanine Transaminase; Apoenzymes; Aspartate Aminotransferases; Biliary Tract Diseases; Biomarkers; C | 2001 |
Pyridoxine and its metabolism in chronic liver disease.
Topics: Alcoholism; Chemical and Drug Induced Liver Injury; Chronic Disease; Humans; Liver; Liver Diseases; | 1977 |
[Status and development of new clinical contrast media for MR diagnosis of liver diseases].
Topics: Acetates; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Liver Diseases; Liver Neoplasms; Mag | 1992 |
7 trials available for pyridoxal phosphate and Liver Dysfunction
| Article | Year |
|---|---|
Adrenal gland enhancement at MR imaging with Mn-DPDP.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenal Glands; Contrast Media; Edetic Acid; Female; Humans; Liver | 1995 |
Mn-DPDP enhanced MR imaging of the liver: analysis of pulse sequence performance.
Topics: Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Image Enhancement; Liver; Liver Diseases; | 1996 |
Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
Topics: Adenoma, Liver Cell; Adult; Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnos | 1999 |
[Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Topics: Adenoma; Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cysts; Diagnosis, Diffe | 2001 |
Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT.
Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; | 2002 |
[Magnetic resonance tomography of the hepatobiliary system: indications, limitations and outlook].
Topics: Biliary Tract Diseases; Biliary Tract Neoplasms; Cholangiography; Contrast Media; Edetic Acid; Gadol | 1992 |
Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Edetic Acid; Evaluation Studies as Topic; Fe | 1992 |
38 other studies available for pyridoxal phosphate and Liver Dysfunction
| Article | Year |
|---|---|
Comparison of blood aminotransferase methods for assessment of myopathy and hepatopathy in Florida manatees (Trichechus manatus latirostris).
Topics: Alanine Transaminase; Animals; Animals, Wild; Aspartate Aminotransferases; Blood Specimen Collection | 2008 |
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.
Topics: Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Di | 2009 |
Exploring multifunctional features of necrosis avid contrast agents.
Topics: Animals; Contrast Media; Edetic Acid; Gadolinium DTPA; Half-Life; Liver Diseases; Liver Neoplasms; M | 2002 |
MnDPDP enhanced magnetic resonance imaging of focal liver lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Cholangiocarcinoma; Contrast Media; Edetic Acid; Female; Focal Nod | 2002 |
MnDPDP-enhanced magnetization transfer MR imaging: implications for effective liver imaging.
Topics: Contrast Media; Edetic Acid; Humans; Image Enhancement; Liver; Liver Diseases; Magnetic Resonance Im | 2003 |
DISTRIBUTION AND ACTIVITY OF ASPARTATE AMINOTRANSFERASE IN SOME RAPIDLY PROLIFERATING TISSUES.
Topics: Animals; Aspartate Aminotransferases; Electrophoresis; Embryo, Mammalian; Embryo, Nonmammalian; Huma | 1965 |
Abnormal regulation of pyridoxal 5'-phosphate in Reye's syndrome.
Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; Female; Humans; Infant; Length of Stay; L | 1983 |
Clinical implications of differences between two recommended procedures for determination of aspartate aminotransferase.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemistry, Clinical; Female; Heart Diseases; Huma | 1983 |
Changes in activation of aspartate aminotransferase by pyridoxal 5'-phosphate after experimental liver damage in rabbits.
Topics: Animals; Aspartate Aminotransferases; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Live | 1982 |
Blood vitamin status (B1, B2, B6, folic acid and B12) in patients with alcoholic liver disease.
Topics: Adult; Alcoholism; Folic Acid; Hepatitis; Humans; Liver Cirrhosis, Alcoholic; Liver Diseases; Middle | 1982 |
Kinetics of alkaline phosphatase in serum of liver diseased, anemic and normal Iraqi individuals.
Topics: Adolescent; Adult; Age Factors; Alkaline Phosphatase; Anemia; Female; Humans; Kinetics; Liver Diseas | 1980 |
Hepatic transaminase activity in alocholic liver disease.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Fatty Liver; Hepatitis; Humans; Liver; Liver Cirr | 1980 |
Hydrolysis of pyridoxal-5'-phosphate in plasma in conditions with raised alkaline phosphate.
Topics: Alkaline Phosphatase; Bone and Bones; Humans; Hydrolysis; Liver Diseases; Pyridoxal Phosphate | 1980 |
Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate.
Topics: Adipose Tissue; Adult; Aged; Contrast Media; Edetic Acid; Female; Gadolinium; Gadolinium DTPA; Human | 1996 |
Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Edetic Acid; Female; Gadolinium; Gado | 1996 |
Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Topics: Adenocarcinoma; Adenoma, Islet Cell; Adipose Tissue; Adult; Aged; Aged, 80 and over; Blood-Brain Bar | 1998 |
Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
Topics: Abdomen; Adult; Aged; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Li | 1998 |
Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: initial observations.
Topics: Adult; Aged; Contrast Media; Diagnosis, Differential; Edetic Acid; Female; Focal Nodular Hyperplasia | 2000 |
Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings.
Topics: Adult; Contrast Media; Dextrans; Edetic Acid; Female; Ferrosoferric Oxide; Gadolinium; Granuloma, Pl | 2002 |
Liver lesions: manganese-enhanced MR and dual-phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis.
Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Edetic Acid; Female; Humans; Liver Diseases; M | 2002 |
IFCC method for aspartate aminotransferase. Appendix A. Description of pertinent factors in obtaining optimal conditions for measurement.
Topics: Aspartate Aminotransferases; Heart Diseases; Humans; Hydrogen-Ion Concentration; Kinetics; Liver Dis | 1976 |
Optimization of methods for aspartate aminotransferase and alanine aminotransferase.
Topics: Alanine Transaminase; Anions; Aspartate Aminotransferases; Glutamates; Heart Diseases; Humans; Hydro | 1978 |
Vitamin B6 and aspartate aminotransferase activity in chronic liver disease.
Topics: Aspartate Aminotransferases; Chronic Disease; Humans; Liver Cirrhosis; Liver Diseases; Necrosis; Pyr | 1978 |
The apoenzyme of aspartate aminotransferase and alanine aminotransferase in the serum of healthy persons and patients suffering from liver diseases.
Topics: Alanine Transaminase; Apoenzymes; Apoproteins; Aspartate Aminotransferases; Enzyme Activation; Femal | 1978 |
Apoenzyme of aspartate aminotransferase in serum in health and disease.
Topics: Apoenzymes; Apoproteins; Aspartate Aminotransferases; Cytoplasm; Female; Humans; Liver Diseases; Mal | 1977 |
Vitamin B6 deficiency in chronic liver disease--evidence for increased degradation of pyridoxal-5'-phosphate.
Topics: Alcoholism; Chronic Disease; Humans; Liver Diseases; Pyridoxal Phosphate; Pyridoxic Acid; Pyridoxine | 1977 |
Aspartate aminotransferase activity in human serum. Factors to be considered in supplementation with pyridoxal 5'-phosphate in vitro.
Topics: Acute Disease; Aspartate Aminotransferases; Enzyme Activation; Evaluation Studies as Topic; Glutamat | 1976 |
Abnormal regulation of plasma pyridoxal 5'-phosphate in patients with liver disease.
Topics: Acute Disease; Adult; Hepatitis, Viral, Human; Humans; Liver Cirrhosis; Liver Diseases; Liver Functi | 1976 |
Activation by pyridoxal 5-phosphate of aspartate transaminase in serum of patients with heart and liver disease.
Topics: Aspartate Aminotransferases; Chronic Disease; Clinical Enzyme Tests; Enzyme Activation; Humans; Live | 1975 |
Manganese (II) N,N'-dipyridoxylethylenediamine-N,N'-diacetate 5,5'-bis(phosphate): clinical experience with a new contrast agent.
Topics: Adult; Contrast Media; Edetic Acid; Female; Humans; Kidney; Liver; Liver Diseases; Magnetic Resonanc | 1992 |
Congenital sideroblastic anaemia with intrauterine symptoms and early lethal outcome.
Topics: Anemia; Anemia, Sideroblastic; Blood Transfusion; Blood Transfusion, Intrauterine; Female; Fetal Dis | 1992 |
Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Edetic Acid; Female; Humans; Liver; Live | 1992 |
Contrast-enhanced magnetic resonance imaging of the liver with Mn-DPDP for known or suspected focal hepatic disease.
Topics: Contrast Media; Drug Evaluation; Edetic Acid; Humans; Liver; Liver Diseases; Magnetic Resonance Imag | 1991 |
Pyridoxal phosphate annuls acetaldehyde inhibition of uridine uptake by hepatocytes.
Topics: Acetaldehyde; Benzylamines; Depression, Chemical; Drug Evaluation; Humans; In Vitro Techniques; Live | 1989 |
MRI measurement of hepatocyte toxicity using the new MRI contrast agent manganese dipyridoxal diphosphate, a manganese/pyridoxal 5-phosphate chelate.
Topics: Animals; Chemical and Drug Induced Liver Injury; Contrast Media; Edetic Acid; Ethanol; Galactosamine | 1989 |
Vitamin B6 concentrations in patients with chronic liver disease and hepatocellular carcinoma.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Humans; Liver Diseases; Liver Neoplasms; Middle | 1986 |
[Clinical trial of a new coenzymatic complex (Ro 8-0743-4)].
Topics: Adult; Aged; Anorexia Nervosa; Cobamides; Coenzymes; Drug Combinations; Evaluation Studies as Topic; | 1972 |
[Studies on the in vitro aging of transaminases in serum and tissue extract].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Cytoplasm; Enzymes; Humans; In Vitro Techniques; | 1965 |